Trial Profile
An exploratory study on efficacy and responders of icaritin plus conventional regimens in the treatment of advanced solid tumors
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Icaritin (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics
- 21 Jul 2017 New trial record